This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Here is Why Growth Investors Should Buy Mettler-Toledo (MTD) Now
by Zacks Equity Research
Mettler-Toledo (MTD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Why Is Mettler-Toledo (MTD) Up 2.5% Since Last Earnings Report?
by Zacks Equity Research
Mettler-Toledo (MTD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Surging Earnings Estimates Signal Upside for Mettler-Toledo (MTD) Stock
by Zacks Equity Research
Mettler-Toledo (MTD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Mettler-Toledo (MTD) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Mettler-Toledo (MTD) possesses solid growth attributes, which could help it handily outperform the market.
Mettler-Toledo's (MTD) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Mettler-Toledo International (MTD).
Mettler-Toledo (MTD) Is Up 18.36% in One Week: What You Should Know
by Zacks Equity Research
Does Mettler-Toledo (MTD) have what it takes to be a top stock pick for momentum investors? Let's find out.
Mettler-Toledo (MTD) Q3 Earnings Top Estimates, Sales Rise Y/Y
by Zacks Equity Research
Mettler-Toledo's (MTD) third-quarter 2020 results reflect benefits from the well-performing Laboratory and Food Retail product lines. Further, a solid momentum across all geographic regions is impressive.
Mettler-Toledo (MTD) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Mettler-Toledo (MTD) delivered earnings and revenue surprises of 16.61% and 7.96%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Mettler-Toledo (MTD) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Mettler-Toledo International's (MTD) third-quarter results are likely to reflect strength across Laboratory and Industrial segments amid the coronavirus pandemic.
Mettler-Toledo (MTD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Mettler-Toledo (MTD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Badger Meter (BMI) Q3 Earnings Top Estimates, Shares Gain
by Zacks Equity Research
Despite COVID-19 uncertainties, Badger Meter (BMI) witnesses solid third-quarter 2020 results with major rise in both top and bottom lines on the back of consistent demand across most end markets.
Mettler-Toledo (MTD) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Mettler-Toledo (MTD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
The Zacks Analyst Blog Highlights: Mettler-Toledo, PerkinElmer, Waters and Bruker
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Mettler-Toledo, PerkinElmer, Waters and Bruker
4 Stocks to Watch on Rising Demand for Scientific Instruments
by Aniruddha Ganguly
The Zacks Instruments - Scientific industry is gaining from strong life science, pharmaceutical and academic end-market demand. Industry participants MTD, PKI, WAT and BRKR are set to gain from rising healthcare spending and exposure to developing economies like China and India.
Why Is Mettler-Toledo (MTD) Up 8% Since Last Earnings Report?
by Zacks Equity Research
Mettler-Toledo (MTD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mettler-Toledo (MTD) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Mettler-Toledo (MTD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Mettler-Toledo (MTD) Q2 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Mettler-Toledo International (MTD) reports decent Q2 results, with impressive growth in China. However, demand in the end markets served by the company is negatively impacted by the COVID-19 pandemic.
Mettler-Toledo (MTD) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Mettler-Toledo (MTD) delivered earnings and revenue surprises of 23.89% and 6.68%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: FTV, PKI, GNRC, CARR and MTD
by Zacks Equity Research
The Zacks Analyst Blog Highlights: FTV, PKI, GNRC, CARR and MTD
Why Mettler-Toledo (MTD) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Mettler-Toledo (MTD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Buy 5 Technology Stocks Set to Beat on Q2 Earnings This Week
by Nalak Das
Several important companies from technology sector will report results this week. A few of them, with a favorable Zacks Rank, are set to beat earnings estimates.
Mettler-Toledo (MTD) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Mettler-Toledo International's (MTD) second-quarter results are likely to reflect strength across Laboratory and Industrial segments amid the coronavirus pandemic.
Mettler-Toledo (MTD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Mettler-Toledo (MTD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mettler-Toledo (MTD) Up 17.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Mettler-Toledo (MTD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mettler-Toledo (MTD) Q1 Earnings Beat, Revenues Fall Y/Y
by Zacks Equity Research
Mettler-Toledo (MTD) first-quarter results reflect negative impact of COVID-19 pandemic.